Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney

Nephron - Experimental Nephrology

Volumn 110, Issue 3, 2008, Pages

  Iguchi, Mitsuko ^a   Kakinuma, Yoshihiko ^a   Kurabayashi, Atsushi ^a   Sato, Takayuki ^a   Shuin, Taro ^a   Hong, Seung Beom ^b   Schmidt, Laura S ^b,c   Furihata, Mutsuo ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

Hypoxia inducible factor; Ischemia reperfusion injury; Ischemic preconditioning; Von Hippel Lindau gene

Indexed keywords

CREATININE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TAMOXIFEN; UBIQUITIN PROTEIN LIGASE E3; VON HIPPEL LINDAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; GENE INACTIVATION; HISTOPATHOLOGY; ISCHEMIC PRECONDITIONING; KIDNEY ARTERY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBULAR DYSFUNCTION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ISCHEMIC PRECONDITIONING; KIDNEY; MICE; REPERFUSION INJURY; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 54849418794     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000166994     Document Type: Article

References (31)

1. Yamada K, Miwa T, Liu J, Nankoku M, Song W: Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 2004;172:3869-3875.
2. Fiaschi-Taesch NM, Santos S, Reddy V, Van Why SK, Philbrick WF, Ortega A, Esbrit P, Orloff JJ, Garcia-Ocaña A: Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and he - patocyte growth factor. J Am Soc Nephrol 2004;15:112-125.
3. Park KM, Byun JY, Kramers C, Kim JI, Huang PL, Bonventre JV: Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003;278:27256-27266.
4. Thakar CV, Zahedi K, Revelo MP, Wang Z, Burnham CE, Barone S, Bevans S, Lentsch AB, Rabb H, Soleimani M: Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest 2005;115:3451-3459.
5. Nath KA, Grande JP, Croatt AJ, Frank E, Caplice NM, Hebbel RP, Katusic ZS: Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol 2005;166:963-972.
6. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S: Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005;115:2894-2903.
7. Zhang Y, Woodward VK, Shelton JM, Richardson JA, Zhou XJ, Link D, Kielar ML, Jeyarajah DR, Lu CY: Ischemia-reperfusion induces G-CSF gene expression by renal medullary thick ascending limb cells in vivo and in vitro. Am J Physiol Renal Physiol 2004;286:F1193-F1201.
8. Kim SJ, Varghese TK, Zhang Z, Zhao LC, Thomas G, Hummel M, Abecassis M: Renal ischemia/reperfusion injury activates the enhancer domain of the human cytomegalovirus major immediate early promoter. Am J Transplant 2005;5:1606-1613.
9. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271-275.
10. Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP: Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling. Science 2002;296:1886-1889.
11. Jones NM, Bergeron M: Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J Cereb Blood Flow Metab 2001;21:1105-1114.
12. Yang YT, Ju TC, Yang DI: Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells. Neurochem 2005;93:513-525.
13. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gass - mann M, Reme CE: HIF-1 induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002;8:718-724.
14. Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, Noiri E, Fujita T, Nangaku M: Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 2003;14:1825-1832.
15. Kojima I, Tanaka T, Inagi R, Kato H, Yamashita T, Sakiyama A, Ohneda O, Takeda N, Sata M, Miyata T, Fujita T, Nangaku M: Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney. J Am Soc Nephrol 2007;18:1218-1226.
16. Carroll VA, Ashcroft M: Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res 2006;66:6264-6270.
17. Haase VH: Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 2006;291:F271-F281.
18. Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ: Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 2005;25:5675-5686.
19. Guo C, Yang W, Lobe CG: A Cre recombinase transgene with mosaic, widespread tamoxifen-inducible action. Genesis 2002;32:8-18.
20. Ma W, Tessarollo L, Hong S, Baba M, Southon E, Back T, Spence S, Lobe C, Sharma N, Maher G, Pack S, Vortmeyer A, Guo C, Zbar B, Schmidt L: Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. Cancer Res 2003;63:5320-5328.
21. Hong SB, Furihata M, Baba M, Zbar B, Schmidt LS: Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis. Lab Invest 2006;86:664-675.
22. Kakinuma Y, Ando M, Kuwabara M, Katare RG, Okudera K, Kobayashi M, Sato T: Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving non-hypoxic induction of HIF-1α. FEBS Lett 2005;579:2111-2118.
23. Kudo Y, Kakinuma Y, Iguchi M, Sato T, Sugiura T, Furihata M, Shuin T: Modification in the von Hippel-Lindau protein is involved in the progression of experimentally induced rat glomerulonephritis. Nephron Exp Nephrol 2007;106:e97-e106.
24. Kudo Y, Kakinuma Y, Mori Y, Morimoto N, Karashima T, Furihata M, Sato T, Shuin T, Sugiura T: Hypoxia-inducible factor-1α is involved in the attenuation of experimentally induced rat glomerulonephritis. Nephron Exp Nephrol 2005;100:e95-e103.
25. Nagashima Y, Miyagi Y, Udagawa K, Taki A, Misugi K, Sakai N, Kondo K, Kaneko S, Yao M, Shuin T: Von Hippel-Lindau tumour suppressor gene: localization of expression by in situ hybridization. J Pathol 1996;180:271-274.
26. Frew IJ, Krek W: Multitasking by pVHL in tumor suppression. Curr Opin Cell Biol 2007;19:685-690.
27. Calzada MJ, Esteban MA, Feijoo-Cuaresma M, Castellanos MC, Naranjo-Suárez S, Temes E, Méndez F, Yánez-Mo M, Ohh M, Landázuri MO: Von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms. Cancer Res 2006;66:1553-1560.
28. Tang N, Mack F, Haase VH, Simon MC, Johnson RS: pVHL function is essential for endothelial extracellular matrix deposition. Mol Cell Biol 2006;26:2519-2530.
29. Kakinuma Y, Katare RG, Arikawa M, Muramoto K, Yamasaki F, Sato T: A HIF-1alpha-related gene involved in cell protection from hypoxia by suppression of mitochondrial function. FEBS Lett 2008;582:332-340.
30. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, Johnson RS: HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005;115:1806-1815.
31. Frede S, Berchner-Pfannschmidt U, Fandrey J: Regulation of hypoxia-inducible factors during inflammation. Methods Enzymol 2007;435:405-419.